Lv1
40 积分 2023-07-18 加入
Association of HSD17B13 rs72613567:TA with non‐alcoholic fatty liver disease in Hispanics/Latinos
14天前
已完结
PCSK9 rs11591147 R46L loss‐of‐function variant protects against liver damage in individuals with NAFLD
14天前
已完结
PCSK9 rs11591147 R46L loss‐of‐function variant protects against liver damage in individuals with NAFLD
15天前
已完结
Effects of PCSK9 inhibitors on metabolic-associated fatty liver disease: a short review
15天前
已完结
PCSK9 deficiency results in increased ectopic fat accumulation in experimental models and in humans
16天前
已完结
PCSK9 inhibitors improve lipid profile and hepatic steatosis surrogate indicators in patients with MAFLD and type 2 diabetes
22天前
已完结
ANGPTL3-lowering strategies to address residual cardiovascular risk
24天前
已完结
Multi-target siRNA: Therapeutic Strategy for Hepatocellular Carcinoma
25天前
已完结
PD-1 blockade unleashes local hepatitis B virus-related B cell response inhibiting hepatocellular carcinoma
1个月前
已完结
Finding the right niche: B-cell migration in the early phases of T-dependent antibody responses
1个月前
已完结
皖公网安备34019202002308
